Regulatory reports / Finland

Regulatory report: medical and recreational cannabis – a global overview

9th November 2020 | Regulatory reports |

Africa
Asia
Australasia
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Europe
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Ireland
Israel
Italy
Japan
Latvia
Lithuania
Malaysia
Mexico
Netherlands
New Zealand
North America
Norway
Peru
Poland
Portugal
Romania
Russia
Serbia
Singapore
Slovenia
South Africa
South America
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Kingdom
United States
Uruguay
World
Regulation and Legislation
Regulatory reports

CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries

CBD considered a medicine: Finland regulatory report

9th December 2019 | Regulatory reports |

Europe
Finland
Regulation and Legislation
Regulatory reports

CBD is considered a medicine in Finland and any CBD-infused product, whether for human or animal use, would be classified as a medicinal product. This report provides a comprehensive overview of the regulatory landscape of CBD in Finland

Regulation of CBD in edibles: an international overview

25th November 2019 | Regulatory reports |

Africa
Asia
Australasia
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Estonia
Europe
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Ireland
Israel
Italy
Japan
Latvia
Lithuania
Malta
Mexico
Netherlands
New Zealand
North America
Peru
Poland
Portugal
Russia
Serbia
Slovakia
South Africa
South America
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
World
Food
Regulation and Legislation
Regulatory reports

The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one of the most popular product categories on the market: edibles